The molecular pathogenesis of Semliki Forest virus: A model virus made useful?

Journal of General Virology

Volumn 80, Issue 9, 1999, Pages 2287-2297

  Atkins, Gregory J ^a   Sheahan, Brian J ^b   Liljeström, Peter ^c,d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

CELL DEATH; DEMYELINATION; IMMUNITY; LABORATORY; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; SAFETY; SEMLIKI FOREST ALPHAVIRUS; TERATOGENESIS; VIRUS INFECTION; VIRUS STRAIN; VIRUS VIRULENCE;

ALPHAVIRUS; SEMLIKI FOREST VIRUS;

EID: 0032819096     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-9-2287     Document Type: Review

References (98)

1. Allsopp, T. E., Scallan, M. F., Williams, A. & Fazakerley, J. K. (1997). Virus infection induces neuronal apoptosis: a comparison with trophic factor withdrawal. Cell Death and Differentiation 5, 50-59.
2. Amor, S., Scallan, M. P., Morris, M. M., Dyson, H. & Fazakerley, J. K. (1996). Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. Journal of General Virology 77, 281-291.
3. Atkins, G. J. (1976). The effect of infection with Sindbis virus and its temperature-sensitive mutants on cellular protein and DNA synthesis. Virology 71, 593-597.
4. Atkins, G. J. (1977). Cytopathogenicity of temperature-sensitive mutants of Sindbis virus. FEMS Microbiology Letters 2, 51-55.
5. Atkins, G. J. (1983). The avirulent A7 strain of Semliki Forest virus has reduced cytopathogenicity for neuroblastoma cells compared to the virulent L10 strain. Journal of General Virology 64, 1401-1404.
6. Atkins, G. J. & Sheahan, B. J. (1982). Semliki Forest virus neurovirulence mutants have altered cytopathogenicity for central nervous system cells. Infection and Immunity 36, 333-341.
7. Atkins, G. J., Carter, J. & Sheahan, B. J. (1982). Effect of alphavirus infection on mouse embryos. Infection and Immunity 38, 1285-1290.
8. Atkins, G. J., Sheahan, B. J. & Dimmock, N. J. (1985). Semliki Forest virus infection of mice: a model for genetic and molecular analysis of viral pathogenicity. Journal of General Virology 66, 395-408.
9. Atkins, G. J., Sheahan, B. J. & Mooney, D. A. (1990). Pathogenicity of Semliki Forest virus for the rat central nervous system and primary rat neural cell cultures - possible implications for the pathogenesis of multiple sclerosis. Neuropathology and Applied Neurobiology 16, 57-68.
10. Atkins, G. J., Balluz, I. M., Glasgow, G. M., Mabruk, M. J. E. M. F., Natale, V. A. I, Smyth, J. M. B. & Sheahan, B. J. (1994). Analysis of the molecular basis of neuropathogenesis of RNA viruses in experimental animals: relevance for human disease? Neuropathology and Applied Neurobiology 20, 91-102.
11. Atkins, G. J., Mabruk, M. J. E. M. F., Glasgow, G. M., Griffin, A. M. & Sheahan, B. J. (1995). Mechanisms of viral teratogenesis. Reviews in Medical Virology 5, 75-86.
12. Atkins, G. J., Sheahan, B. J. & Liljeström, P. (1996). Manipulation of the Semliki Forest virus genome and its potential for vaccine construction. Molecular Biotechnology 5, 33-38.
13. Balluz, I. M., Glasgow, G. M., Killen, H. M., Mabruk, M. J. E. M. F., Sheahan, B. J. & Atkins, G. J. (1993). Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage. Neuropathology and Applied Neurobiology 19, 233-239.
14. Barrett, A. D. T. & Dimmock, N. J. (1984). Modulation of Semliki Forest virus infection of mice by defective-interfering virus. Journal of Infectious Diseases 150, 98-104.
15. Barrett, P.N., Sheahan, B. J. & Atkins, G. J. (1980). Isolation and preliminary characterization of mutants of Semliki Forest virus with altered virulence. Journal of General Virology 49, 141-148.
16. Berglund, P., Sjöberg, M., Atkins, G. J., Sheahan, B. J., Garoff, H. & Liljeström, P. (1993). Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Bio/Technology 11, 916-920.
17. Berglund, P., Quesada-Rolander, M., Putkonen, P., Biberfeld, G., Thorstensson, R. & Liljeström, P. (1997). Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenged with a high dose of SHIV-4 virus. AIDS Research and Human Retroviruses 13, 1487-1495.
18. Berglund, P., Fleeton, M., Smerdou, C., Tubulekas, I., Sheahan, B. J., Atkins, G. J. & Liljeström, P. (1998a). Vaccination with recombinant suicidal DNA/RNA. In New Developments and New Applications in Animal Cell Technology, pp. 583-590. Edited by O. Merten, P. Perrin & B. Griffiths. Dordrecht: Kluwer Academic Publishers.
19. Berglund, P., Smerdou, C., Fleeton, M. N., Tubulekas, I. & Liljeström, P. (1998b). Enhancing immune responses using suicidal DNA vaccines. Nature Biotechnology 16, 562-565.
20. Berglund, P., Fleeton, M. N., Smerdou, C. & Liljeström, P. (1999). Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice. Vaccine 17, 497-507.
21. Bradish, C.J., Allner, K. & Maber, H.B. (1971). The virulence of original and derived strains of Semliki forest virus for mice, guinea-pigs and rabbits. Journal of General Virology 12, 141-160.
22. Butt, A. M., Tutton, M. G., Kirvell, S. L., Amor, S. & Jenkins, H. G. (1996). Morphology of oligodendrocytes during demyelination in optic nerves of mice infected with Semliki Forest virus. Neuropathology and Applied Neurobiology 22, 540-547.
23. Donnelly, S. M., Sheahan, B. J. & Atkins, G. J. (1997). Long-term effects of Semliki Forest virus infection in the mouse central nervous system. Neuropathology and Applied Neurobiology 23, 235-241.
24. Dropulic, B. & Masters, C. L. (1990). Entry of neurotropic arboviruses into the central nervous system: an in vitro study using mouse brain endothelium. Journal of Infectious Diseases 161, 685-691.
25. E.C. Council Directive 93/88/EEC (1993). Amending directive 90/679/EEC on the protection of workers from risks related to exposure to biological agents at work. Official Journal of the European Communities 268, 71-82.
26. Erälinna, J. P., Soiluhänninen, M., Roytta, M., Ilonen, J., Mäkelä, M., Salmi, A. & Salonen, R. (1994). Facilitation of experimental allergic encephalomyelitis by irradiation and virus infection: role of inflammatory cells. Journal of Neuroimmunology 55, 81-90.
27. Fazakerley, J. K. & Webb, H. E. (1987). Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice. Journal of General Virology 68, 377-386.
28. Fazakerley, J. K., Pathak, S., Scallan, M., Amor, S. & Dyson, H. (1993). Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Virology 195, 627-637.
29. Federal Register 58 no. 19, 9 (1993). Addition of Appendix DL-X to the NIH guidelines regarding Semliki Forest virus. Human Gene Therapy 5, 401.
30. Fernandez, I, M., Snijders, A., Benaissatrouw, B. J., Harmsen, M., Snippe, H. & Kraaijeveld, C. A. (1993). Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus. Journal of Virology 67, 5843-5848.
31. Fleeton, M. N., Sheahan, B. J., Gould, E. A., Atkins, G. J. & Liljeström, P. (1999). Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge. Journal of General Virology 80, 1189-1198.
32. Frolov, I. & Schlesinger, S. (1994). Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells. Journal of Virology 68, 1721-1727.
33. Fujiwara, T., Cai, D. W., Georges, R. N., Mukhopadhyay, T., Grimm, E. A. & Roth, J. A. (1994). Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. Journal of the National Cancer Institute 86, 1458-1462.
34. Gates, M. C., Sheahan, B. J. & Atkins, B. J. (1984). The pathogenicity of the M9 mutant of Semliki Forest virus in immune compromised mice. Journal of General Virology 65, 73-80.
35. Gates, M. C., Sheahan, B. J., O'Sullivan, M. A. & Atkins, G. J. (1985). The pathogenicity of the A7, M9 and L10 strains of Semliki Forest virus for weanling mice and primary mouse brain cell cultures. Journal of General Virology 66, 2365-2373.
36. Glasgow, G. M., Sheahan, B. J., Atkins, G. J., Wahlberg, J. M., Salminen, A. & Liljeström, P. (1991). Two mutations in the envelope glycoprotein-E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice. Virology 185, 741-748.
37. Glasgow, G. M., Killen, H. M., Liljeström, P., Sheahan, B. J. & Atkins, G. J. (1994). A single amino acid change in the E2 spike protein of a virulent strain of Semliki Forest virus attenuates pathogenicity. Journal of General Virology 75, 663-668.
38. Glasgow, G. M., McGee, M. M., Mooney, D. A., Sheahan, B. J. & Atkins, G. J. (1997). Death mechanisms in cultured cells infected by Semliki Forest virus. Journal of General Virology 78, 1559-1563.
39. Glasgow, G. M., McGee, M. M., Tarbatt, C. J., Mooney, D. A., Sheahan, B. J. & Atkins, G. J. (1998). The Semliki Forest virus vector induces p53-independent apoptosis. Journal of General Virology 79, 2405-2410.
40. Grandgirard, D., Studer, E., Monney, L., Belser, T., Fellay, I., Borner, C. & Michel, M. R. (1998). Alphaviruses induce apoptosis in Bcl-2 overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO Journal 17, 1268-1278.
41. Hearne, A. M., O'Sullivan, M. A. & Atkins, G. J. (1986). Infection of cultured early mouse embryos with Semliki Forest and rubella viruses. Journal of General Virology 67, 1091-1098.
42. Hearne, A. M., O'Sullivan, M. A. & Atkins, G. J. (1987). Isolation and preliminary characterization of Semliki Forest virus mutants with altered pathogenicity for mouse embryos. Journal of General Virology 68, 107-113.
43. Kaluza, G., Lell, G., Reimacher, M., Stitz, L. & Willems, W. R. (1987). Neurogenic spread of Semliki Forest virus in mice. Archives of Virology 93, 97-110.
44. Kibler, K. V., Shors, T., Perkins, K. B., Zeman, C. C., Banaszak, M. P., Biesterfeldt, J., Langland, J. O. & Jacobs, B. L. (1997). Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. Journal of Virology 71, 1992-2003.
45. Kinney, R. M., Chang, G.-J., Tsuchiya, K. R., Sneider, J. M., Roerig, J. T., Woodward, T. M. & Trent, D. W. (1993). Attenuation of Venezuelan equine encephalitis strain TC-83 is encoded by the 5′ noncoding region and the E2 envelope glycoprotein. Journal of Virology 67, 1269-1277.
46. Kohno, A., Emi, N., Kasai, M., Tanimoto, M. & Saito, H. (1998). Semliki Forest virus-based DNA expression vector - transient protein production followed by cell death. Gene Therapy 5, 415-418.
47. Kujala, P., Rikkonene, M., Ahola, T., Kelve, M., Saarma, M. & Kääriäinen, L (1997). Monoclonal antibodies specific for Semliki Forest virus replicase protein nsP2. Journal of General Virology 78, 343-351.
48. Lee, S. B. & Esteban, M. (1994). The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199, 491-496.
49. Liljeström, P. (1994). Alphavirus expression systems. Current Opinion in Biotechnology 5, 495-500.
50. Liljeström, P. & Garoff, H. (1991). A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/ Technology 9, 1356-1361.
51. Liljeström, P., Lusa, S., Huylebroeck, D. & Garoff, H. (1991). In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular weight membrane protein modulates virus release. Journal of Virology 65, 4107-4113.
52. Lundström, K., Pralong, W. & Martinou, J.-C. (1997). Anti-apoptotic effect of Bcl-2 overexpression in RIN cells infected with Semliki Forest virus. Apoptosis 2, 189-191.
53. Mabruk, M. J. E. M. F., Flack, A. M., Glasgow, G. M., Smyth, J. M. B., Folan, J. C., Bannigan, J. G., O'Sullivan, M. A., Sheahan, B. J. & Atkins, G. J. (1988). Teratogenicity of the Semliki Forest virus mutant ts 22 for the foetal mouse: induction of skeletal and skin defects. Journal of General Virology 69, 2755-2762.
54. Mabruk, M. J. E. M. F., Glasgow, G. M., Flack, A. M., Folan, J. C., Bannigan, J. G., Smyth, J. M. B., O'Sullivan, M. A., Sheahan, B. J. & Atkins, G. J. (1989). Effect of infection with the ts 22 mutant of Semliki Forest virus on development of the central nervous system in the fetal mouse. Journal of Virology 63, 4027-4033.
55. McIntosh, B. M., Brookworth, C. & Kokernot, R. H. (1961). Isolation of Semliki Forest virus from Aëdes (Aëdimorphus) argenteopunctatus (Theobald) collected in Portuguese East Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 55, 192-198.
56. Mathiot, C. C., Grimaud, G., Garry, P., Bouquety, J. C, Mada, A., Daguisy, A. M. & Georges, A. J. (1990). An outbreak of human Semliki Forest virus infection in Central African Republic. American Journal of Tropical Medicine and Hygiene 42, 386-393.
57. Meek, A. D. J., Faragher, S. G., Weir, R. C. & Dalgarno, L. (1989). Genetic and phenotypic studies on Ross River virus variants of enhanced virulence selected during mouse passage. Virology 172, 399-407.
58. Mokhtarian, F. & Swoveland, P. (1987). Predisposition to EAE induction in resistant mice by prior infection with Semliki Forest virus. Journal of Immunology 138, 3264-3268.
59. Mokhtarian, F., Shi, Y., Zhu, P. F. & Grob, D. (1994). Immune responses, and autoimmune outcome, during virus infection of the central nervous system. Cellular Immunology 157, 195-210.
60. Mokhtarian, F., Wesselingh, S., Choi, S., Maeda, A., Griffin, D. E., Sobel, R. A. & Grob, D. (1996). Production and role of cytokines in the CNS of mice with acute viral encephalomyelitis. Journal of Neuroimmunology 66, 11-22.
61. Morris, M. M., Dyson, H., Baker, D., Harbige, L. S., Fazakerley, J. K. & Amor, S.A. (1997). Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection. Journal of Neuroimmunology 74, 185-197.
62. Mossman, S., Bex, F., Berglund, P., Arthos, J., O'Neill, S. P., Riley, D., Maul, D. H., Bruck, C., Momin, P., Burny, A., Fultz, P. N., Mullins, J. I., Liljeström, P. & Hoover, E. A. (1996). Protection against lethal SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by gp120 subunit vaccine. Journal of Virology 70, 1953-1960.
63. Oliver, K. R. & Fazakerley, J. K. (1998). Transneuronal spread of Semliki Forest virus in the developing mouse olfactory system is determined by neuronal maturity. Neurosciences 82, 867-877.
64. Oliver, K. R., Scallan, M. F., Dyson, H. & Fazakerley, J. K. (1998). Susceptibility to a neurotropic virus and its changing distribution in the developing brain is a function of CNS maturity. Journal of Neunvirology 3, 38-48.
65. Pence, D. F., Davis, N. L. & Johnston, R. E. (1990). Antigenic and genetic characterization of Sindbis virus monoclonal antibody escape mutants which define a pathogenesis domain on glycoprotein E2. Virology 175, 41-49.
66. Phenix, K. V., McKenna, B., Fitzpatrick, R., Vaughan, L., Atkins, G., Liljeström, P. & Todd, D. (1999). Evaluation of the Semliki Forest virus expression system as a novel approach for antigen delivery and expression in fish. Marine Microbiology (in press).
67. Razvi, E. S. & Welsh, R. M. (1995). Apoptosis in viral infections. Advances in Virus Research 45, 1-60.
68. Rikkonen, M. (1996). Functional significance of the nuclear-targeting and NTP-binding motifs of Semliki Forest virus nonstructural protein nsP2. Virology 218, 352-361.
69. Rikkonen, M., Peränen, J. & Kääriäinen, L. (1992). Nuclear and nucleolar targeting signals of Semliki forest virus nonstructural protein nsP2. Virology 189, 462-473.
70. Sammin, D. J., Butler, D., Atkins, G. J. & Sheahan, B. J. (1999). Cell death mechanisms in the olfactory bulb of rats infected intranasally with Semliki Forest virus. Neuropathology and Applied Neurobiology (in press).
71. Santagati, M. G. (1998). Virulence determinants of Semliki Forest virus. PhD thesis, University of Turku, Finland.
72. Santagati, M. G., Itäranta, P. V., Koskimies, P. R., Määttä, J. A., Salmi, A. A. & Hinkkanen, A. E. (1994). Multiple repeating motifs are found in the 3′-terminal nontranslated region of Semliki Forest virus A7 variant genome. Journal of General Virology 75, 1499-1504.
73. Santagati, M. G., Määttä, J. A., Itäranta, J. A., Salmi, A. A. & Hinkkanen, A. E. (1995). The Semliki Forest virus E2 gene as a virulence determinant. Journal of General Virology 76, 47-52.
74. Santagati, M. G., Määttä, J. A., Röyttä, M., Salmi, A. A. & Hinkkanen, A. E. (1998). The significance of the 3′-nontranslated region and E2 amino acid mutations in the virulence of Semliki Forest virus in mice. Virology 243, 66-77.
75. Scallan, M. F., Allsopp, T. E. & Fazakerley, J. K. (1997). bcl-2 acts early to restrict Semliki Forest virus replication and delays virus-induced programmed cell death. Journal of Virology 71, 1583-1590.
76. Sheahan, B. J., Ibrahim, M. A. & Atkins, G. J. (1996). Demyelination of olfactory pathways in mice following intranasal infection with the avirulent A7 strain of Semliki Forest virus. European Journal of Veterinary Pathology 2, 117-125.
77. Smerdou, C. & Liljeström, P. (1999a). Two-helper RNA system for production of recombinant Semliki Forest virus particles. Journal of Virology 73, 1092-1098.
78. Smerdou, C. & Liljeström, P. (1999b). Non-viral amplification systems for gene transfer: vectors based on alphaviruses. Current Opinion in Molecular Therapy (in press).
79. Smithbum, K. C. & Haddow, A. J. (1944). Semliki Forest virus. I. Isolation and pathogenic properties. Journal of Immunology 49, 141-157.
80. Smyth, J. M. B., Sheahan, B. J. & Atkins, G. J. (1990). Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice. Journal of General Virology 71, 2575-2583.
81. Snijders, A., Benaissatrouw, B. J., Snippe, H. & Kraaijeveld, C. A. (1992). Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B-cell and T-cell epitopes. Journal of General Virology 73, 2267-2272.
82. Soiluhänninen, M., Erälinna, J. P., Hukkanen, V., Röyttä, M., Salmi, A. A. & Salonen, R. (1994). Semliki Forest virus infects mouse brain endothelial cells and causes blood-brain barrier damage. Journal of Virology 68, 6291-6298.
83. Soiluhänninen, M., Röyttä, M., Salmi, A. A. & Salonen, R. (1997). Semliki Forest virus infection leads to increased expression of adhesion molecules on splenic T-cells and on brain vascular endothelium. Journal of Neurovirology 3, 350-360.
84. Strauss, J. H. & Strauss, E. G. (1994). The alphaviruses: gene expression, replication and evolution. Microbiological Reviews 58, 491-562.
85. Subak-Sharpe, I., Dyson, H. & Fazakerley, J. K. (1993). In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. Journal of Virology 67, 7629-7633.
86. Tarbatt, C. J., Glasgow, G. M., Mooney, D. A., Sheahan, B. J. & Atkins, G. J. (1997). Sequence analysis of the avirulent, demyelinating A7 strain of Semliki Forest virus. Journal of General Virology 78, 1551-1557.
87. Thomson, M. & Dimmock, N. J. (1994). Sequences of defective interfering Semliki Forest virus necessary for antiviral activity in vivo and interference and propagation in vitro. Virology 199, 354-365.
88. Thomson, M., White, C. L. & Dimmock, N. J. (1998). The genomic sequences of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo. Virology 241, 215-223.
89. Tubulekas, I., Berglund, P., Fleeton, M. & Liljeström, P. (1997). Alphavirus expression vectors and their use as recombinant vaccines - a minireview. Gene 190, 191-195.
90. Tucker, P. C., Strauss, E. G., Kühn, R. J., Strauss, J. H. & Griffin, D. E. (1993). Viral determinants of age-dependent virulence of Sindbis virus for mice. Journal of Virology 65, 4605-4610.
91. Ubol, S., Tucker, P. C., Griffin, D. E. & Hardwick, J. M. (1994). Neurovirulent strains of alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoprotein. Proceedings of the National Academy of Sciences, USA 91, 5202-5206.
92. U.S. Department of Health & Human Services (1993). Biosafety in Microbiological and Biomedical Laboratories. HHS Publication no. (CDC) 93-8395, 3rd edn.
93. Vaughan, L. M., Fitzpatrick, R. M., McKenna B. & Atkins, G. J. (1998). Molecular approaches to fish vaccine design. In Methodology in fish Disease Research, pp. 161-166. Edited by A. Barnes, G. Davidson, M. Hiney & D. McIntosh. Aberdeen: Albion Press.
94. White, C. L., Thomson, M. & Dimmock, N. J. (1998). Deletion analysis of a defective interfering Semliki Forest virus RNA genome defines a region in the nsP2 sequence that is required for efficient packaging of the genome into virus particles. Journal of Virology 72, 4320-4326.
95. Willems, W. R., Kaluza, G., Boschek, C. B., Bauer, H., Hager, H., Schütz, H.-J. & Feistner, H. (1979). Semliki Forest virus: cause of a fatal case of human encephalitis. Science 203, 1127-1129.
96. Winkler, W. G. & Blenden, D. C. (1995). Transmission and control of viral zoonoses in the laboratory. In Laboratory Safety: Principles and Practices, 2nd edn. Edited by D. O. Fleming, J. H. Richardson, J. L. Tulis & D. Vesley. Washington, DC: American Society for Microbiology.
97. Zhou, X. P., Berglund, G., Rhodes, G., Parker, S. E., Jondal, M. & Liljeström, P. (1994). Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12, 1510-1514.
98. Zhou, X. P., Berglund, G., Zhao, H., Liljeström, P. & Jondal, M. (1995). Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proceedings of the National Academy of Sciences, USA 92, 3009-3013.